Page last updated: 2024-09-05

erlotinib hydrochloride and Hypoalbuminemia

erlotinib hydrochloride has been researched along with Hypoalbuminemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benesova, L; Bortlicek, Z; Fiala, O; Finek, J; Kucera, R; Minarik, M; Pesek, M; Racek, J; Sorejs, O; Topolcan, O	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Hypoalbuminemia

Article	Year
Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib. Neoplasma, 2016, Volume: 63, Issue:3 Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cohort Studies; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Hypoalbuminemia; Lung Neoplasms; Male; Neoplasm Staging; Predictive Value of Tests; Progression-Free Survival; Proportional Hazards Models; Protein Kinase Inhibitors; Retrospective Studies; Serum Albumin; Treatment Outcome	2016

Article

Year

Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib.

Neoplasma, 2016, Volume: 63, Issue:3

Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cohort Studies; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Hypoalbuminemia; Lung Neoplasms; Male; Neoplasm Staging; Predictive Value of Tests; Progression-Free Survival; Proportional Hazards Models; Protein Kinase Inhibitors; Retrospective Studies; Serum Albumin; Treatment Outcome

2016